There have been 91 cases of measles in the last week and a half, bringing the number of cases so far this year to 971; a coalition of civil rights group is suing the Trump administration over the recently issued conscience protection rule; Oklahoma's opioid trial against Johnson & Johnson has started.
The number of measles cases in the United States has reached 971, including 91 in the past week and a half, according to the CDC. Just 5 months into the year, this is the greatest number of cases reported since 1992, when 963 cases were reported for the entire year. The CDC said it continues to work with affected state and local health departments to get control of ongoing outbreaks, including those in New York City and Rockland County, New York, which have continued for nearly 8 months. According to the CDC, if these 2 outbreaks continue through summer and fall, the United States may lose its measles elimination status.A group of civil rights groups have filed a lawsuit against the Trump administration, arguing that the recently issued conscience protection rule that allows healthcare providers to refuse to provide care if it goes against their religious beliefs is unconstitutional. The coalition, which includes Lambda Legal and the Center for Reproductive Rights, said that the rule will cause “mass confusion among healthcare providers and is completely infeasible to implement.” According to The Hill, they also argue that healthcare providers may scrap reproductive and LGBTQ services as a whole, leaving millions without care.Oklahoma’s opioid trial against Johnson & Johnson has started, with Oklahoma Attorney General Mike Hunter telling a judge that the drug company’s greed for more sales fueled the opioid epidemic in the state, and that the company should pay billions of dollars as compensation. The attorney general added that Johnson & Johnson used a “deceitful, multibillion-dollar brainwashing campaign” to dupe doctors into prescribing opioids for unapproved ailments, reported Bloomberg. Oklahoma’s lawsuit is 1 of more than 1600 filed and the first to go to trial.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More